Skip to main content
Book cover

Andrology pp 109–118Cite as

Endocrine Laboratory Diagnosis

  • Chapter
  • 2553 Accesses

The evaluation of serum levels of LH and FSH in combination with testosterone provides important information to pinpoint the localization of hypogonad-ism, which is then decisive for adequate therapy.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Anand-Ivell R, Wohlgemuth J, Haren MT, Hope PJ, Hatzinikolas G, Wittert G, Ivell R (2006) Peripheral INSL3 concentrations decline with age in a large population of Australian men. Int J Androl 29:618–626

    Article  CAS  PubMed  Google Scholar 

  • Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB (2007) Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92:4241–4247

    Article  CAS  PubMed  Google Scholar 

  • Ballescá JL, Balasch J, Calafell JM, Alvarez R, Fábregues F, de Osaba MJ, Ascaso C, Vanrell JA (2000) Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia. Hum Reprod 15:1734–1738

    Article  PubMed  Google Scholar 

  • Bay K, Virtanen HE, Hartung S, Ivell R, Main KM, Skakkebaek NE, Andersson AM, Nordic Cryptorchidism Study Group, Toppari J (2007) Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypotha-lamic-pituitary-gonadal axis activation, and cryptorchidism. J Clin Endocrinol Metab 92:4020–4027

    Article  CAS  PubMed  Google Scholar 

  • Bergmann M, Behre HM, Nieschlag E (1994) Serum FSH and testicular morphology in male infertility. Clin Endocrinol 40:133–136

    Article  CAS  Google Scholar 

  • Bhagavath B, Layman LC (2007) The genetics of hypogonado-tropic hypogonadism. Semin Reprod Med 25:272–286

    Article  CAS  PubMed  Google Scholar 

  • Bouligand J, Ghervan C, Tello JA, Brailly-Tabard S, Salenave S, Chanson P, Lombès M, Millar RP, Guiochon-Mantel A, Young J (2009) Isolated familial hypogonadotropic hypogo-nadism and a GnRH1 mutation. N Engl J Med 360: 2742–2748

    Article  CAS  PubMed  Google Scholar 

  • Diver MJ, Imtiaz KE, Ahmad AM, Vora JP, Fraser WD (2003) Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol 58:710–717

    Article  CAS  Google Scholar 

  • Foresta C, Zuccarello D, Garolla A, Ferlin A (2008) Role of hormones, genes and environment in human cryptorchidism. Endocr Rev 29:560–580

    Article  CAS  PubMed  Google Scholar 

  • Goldstein M, Tanrikut C (2006) Microsurgical management of male infertility. Nat Clin Pract Urol 3:381–391

    Article  PubMed  Google Scholar 

  • Goulis DG, Tsametis C, Iliadou PK, Polychronou P, Kantartzi PD, Tarlatzis BC, Bontis IN, Papadimas I (2009) Serum inhibin B and anti-Müllerian hormone are not superior to follicle-stimulating hormone as predictors of the presence of sperm in testicular fine-needle aspiration in men with azoo-spermia. Fertil Steril 91:1279–1284

    Article  CAS  PubMed  Google Scholar 

  • Granger DA, Shirtcliff EA, Booth A, Kivlighan KT, Schwartz EB (2004) The “trouble” with salivary testosterone. Psychoneu-roendocrinology 29:1229–1240

    Article  CAS  Google Scholar 

  • Gsponer J, De Tribolet N, Déruaz JP, Janzer R, Uské A, Mirimanoff RO, Reymond MJ, Rey F, Temler E, Gaillard RC, Gomez F (1999) Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine 78:236–269

    Article  CAS  PubMed  Google Scholar 

  • Huhtaniemi I, Alevizaki M (2006) Gonadotrophin resistance. Best Pract Res Clin Endocrinol Metab 20:561–576

    Article  CAS  PubMed  Google Scholar 

  • Huhtaniemi I, Themmen AP (2005) Mutations in human gonad-otropin and gonadotropin-receptor genes. Endocrine 26: 207–217

    Article  CAS  PubMed  Google Scholar 

  • Josso N, Picard J Y, Rey R, di Clemente N (2006) Testicular anti-Müllerian hormone: history, genetics, regulation and clinical applications. Pediatr Endocrinol Rev 3:347–358

    PubMed  Google Scholar 

  • Kelleher S, Conway AJ, Handelsman DJ (2004) Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 89:3813–3817

    Article  CAS  PubMed  Google Scholar 

  • Le Moli R, Endert E, Fliers E, Prummel MF, Wiersinga WM (2003) Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia. Neth J Med 61:44–48

    PubMed  Google Scholar 

  • Lee MM, Donahoe PK, Silverman BL, Hasegawa T, Hasegawa Y, Gustafson ML, Chang YC, MacLaughlin DT (1997) Measurements of serum mullerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med 336:1480–1486

    Article  CAS  PubMed  Google Scholar 

  • Licea-Perez H, Wang S, Szapacs ME, Yang E (2008) Development of a highly sensitive and selective UPLC/MS/MS method for the simultaneous determination of testosterone and 5α-dihydrotestosterone in human serum to support testosterone replacement therapy for hypogonadism. Steroids 73:601–610

    Article  CAS  PubMed  Google Scholar 

  • Meachem SJ, Nieschlag E, Simoni M (2001) Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol 145:561–571

    Article  CAS  PubMed  Google Scholar 

  • Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FC (2004) Testosterone replacement therapy: current trends and future directions. Hum Rreprod Update 10:409–419

    Article  CAS  Google Scholar 

  • Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FC (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 3: 125–127

    Article  Google Scholar 

  • O'Connor AE, De Kretser DM (2004) Inhibins in normal male physiology. Semin Reprod Med 22:177–185

    Article  PubMed  Google Scholar 

  • Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92:405–413

    Article  CAS  PubMed  Google Scholar 

  • Roy P, Alevizaki M, Huhtaniemi I (2008) In vitro bioassays for androgens and their diagnostic applications. Hum Reprod Update 14:73–82

    Article  CAS  PubMed  Google Scholar 

  • Schürmeyer T, Jung K, Nieschlag E (1984) The effect of an 1100 km run on testicular, adrenal and thyroid hormones. Int J Androl 7:276–282

    Article  PubMed  Google Scholar 

  • Sequera AM, Fideleff HL, Boquete HR, Pujol AB, Suárez MG, Ruibal GF (2002) Basal ultrasensitive LH assay: a useful tool in the early diagnosis of male pubertal delay? J Pediatr Endocrinol Metab 15:589–596

    CAS  PubMed  Google Scholar 

  • Simoni M (2004) Methodology for measuring testosterone, DHT and SHBG in a clinical setting. In: Nieschlag E, Behre HM (eds) Testosterone action, deficiency, substitution, 3rd edn. Cambridge University Press, Cambridge, pp 641–664

    Chapter  Google Scholar 

  • Simoni M, Nieschlag E (1991) In vitro bioassays of follicle-stimulating hormone: methods and clinical applications. J Endocrinol Invest 14:983–997

    CAS  PubMed  Google Scholar 

  • Simoni M, Gromoll J, Nieschlag E (1997) The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18:739–773

    Article  CAS  PubMed  Google Scholar 

  • Sinisi AA, Esposito D, Maione L, Quinto MC, Visconti D, De Bellis A, Bellastella A, Conzo G, Bellastella G (2008) Seminal anti-mullerian hormone level is a marker of sper-matogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Hum Reprod 23:1029–1034

    Article  CAS  PubMed  Google Scholar 

  • Smith TP, Kavanagh L, Healy ML, McKenna TJ (2007) Technology insight: measuring prolactin in clinical samples. Nat Clin Pract Endocrinol Metab 3:279–289

    Article  CAS  PubMed  Google Scholar 

  • Stroud MA, Ritz P, Coward PA, Sawyer MB, Constantin-Teodosiu D, Greenhaff PL, Macdonald IA (1997) Energy expenditure using isotope-labelled water (2H218O), exercise performance, skeletal muscle enzyme activities and plasma biochemical parameters in humans during 95 days of enducrance exercise with inadequate energy intake. Eur J Appl Physiol Occup Physiol 76:243–252

    Article  CAS  PubMed  Google Scholar 

  • Sussman EM, Chudnovsky A, Niederberger CS (2008) Hormonal evaluation of the infertile male: has it evolved? Urol Clin North Am 35:147–155

    Article  PubMed  Google Scholar 

  • Tüttelmann F, Dykstra N, Themmen AP, Visser JA, Nieschlag E, Simoni M (2009) Anti-Müllerian hormone in men with normal and reduced sperm concentration and men with malde-scended testes. Fertil Steril 91:1812–1819

    Article  PubMed  Google Scholar 

  • Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666–3672

    Article  CAS  PubMed  Google Scholar 

  • von Eckardstein S, Simoni M, Bergmann M, Weinbauer GF, Gassner P, Schepers AG, Nieschlag E (1999) Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab 84:2496–2501

    Article  Google Scholar 

  • Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC (2009) Investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Androl 32:1–10

    Article  PubMed  Google Scholar 

  • Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D (2008) European male aging study group. J Clin Endocrinol Metab 93:2737–2745

    Article  CAS  PubMed  Google Scholar 

  • Zitzmann M, Nieschlag E (2001) Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs. Eur J Endocrinol 144:183–197

    Article  CAS  PubMed  Google Scholar 

  • Zitzmann M, Nieschlag E (2003) Hypogonadism in the elderly men. Reliable diagnosis and therapy. Internist 44:1313–1321

    Article  CAS  PubMed  Google Scholar 

  • Zitzmann M, Faber S, Nieschlag E (2006a) Association of spe-cific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91:4335–4343

    Article  CAS  PubMed  Google Scholar 

  • Zitzmann M, Nordhoff V, von Schönfeldt V, Nordsiek-Mengede A, Kliesch S, Schüring AN, Luetjens CM, Kamischke A, Cooper T, Simoni M, Nieschlag E (2006b) Elevated follicle-stimulating hormone levels and the chances for azoospermic men to become fathers after retrieval of elongated spermatids from cryopreserved testicular tissue. Fertil Steril 86:339–347

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manuela Simoni .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Simoni, M., Nieschlag, E. (2010). Endocrine Laboratory Diagnosis. In: Nieschlag, E., Behre, H.M., Nieschlag, S. (eds) Andrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78355-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-78355-8_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-78354-1

  • Online ISBN: 978-3-540-78355-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics